Precision Epitope-engineering in Hematopoietic Stem and Progenitor Cells enables CD123 CAR-T cell immunotherapy for acute myeloid leukemia_2

Published: 20 August 2024| Version 1 | DOI: 10.17632/7tzk9r4mn8.1
Contributors:
ying zhang,

Description

This dataset contains the raw FACS data of in vivo experiments without CART or AML used to generate the Figures in the paper titled "Precision Epitope-engineering in Hematopoietic Stem and Progenitor Cells enables CD123 CAR-T cell immunotherapy for acute myeloid leukemia".

Files

Institutions

Wuhan University

Categories

Hematopoietic Stem Cell, Acute Leukemia

Licence